Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us] DOCKETS ENTERED on October 1, 2001 TABLE OF CONTENTS Hyper links are part of the Docket title - not all dockets/documents are linked NOTE: Documents received by the Dockets Management Branch "MAY" be posted on the Internet.PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence. |
|
74P-0001 Vinyl Chloride as ingredient Drug/Cosmetic Aerosol Products
BKG 1 BACKGROUND Vol#: 1
C 1 City of Syracuse,Department of Law Vol#: 1
C 2 American Academy of Pediatrics Vol#: 1
C 3 Continental Oil Company Vol#: 1
CP 1 Health Research Group Vol#: 1
NPR 1 Vol#: 1
75N-183H Health-Care Antiseptic Drug Products for OTC Human Use
RPT 5 Steris Corporation Vol#: 111
76N-052G OTC general comments & combinations
NFR 3 Vol#: 35
97D-0318 Revised Precautionary Measure to Reduce Transmission of CJD
NEC 1 Vol#: 1
97N-0511 Procedures the safe and sanitary processing/importing juice
C 769 National Food Processors Assn Vol#: 31
98N-0359 Program priorities/Center for Food Safety & Applied Nutritin
C 72 Biotechnology Industry Organization Vol#: 6
98P-0151 Introduction Of Downed Cattle Into The Food Supply
C 5224 Ms. Natalie Kriegler Vol#: 180
C 5225 Benjamin Bristell Vol#: 180
C 5226 Crystal Nilsson Vol#: 180
C 5227 Hallie Hendricks Vol#: 180
C 5228 Jane Hamilton Vol#: 180
EMC 2312 Gary Farr Vol#: 180
EMC 2313 Jan Vol#: 180
EMC 2314 Monica Gonzales Vol#: 180
EMC 2315 Keith Landon Vol#: 180
EMC 2316 Meredith Erickson Vol#: 180
EMC 2317 Susan Siminow Vol#: 180
EMC 2318 Eleanor Thomas Vol#: 180
EMC 2319 Billie B. Nixon Vol#: 180
98P-0610 Convert Allegra/Allegra-D,Claritin/Claritin-D,Zyrtec to OTC
C 44 Directors Guild of America Vol#: 5
00D-1598 Voluntary Labeling for Bioengineered Foods
C 9490 Form Letter Count 259 Vol#: 504
C 9491 Form Letter Count 39 Vol#: 505
C 9492 Form Letter Count 40 Vol#: 506
C 9493 Form Letter Count 7,852 signatures Vol#: 507
C 9494 Janie Nobles Vol#: 476
C 9495 Mary Hartup Vol#: 476
C 9496 Mary Bateman Vol#: 476
C 9497 No signature Vol#: 476
C 9498 Belynda Justice Vol#: 476
00P-1210 Restrict Sale of Coal Tar-Containing Products
LET 3 HFC-1 to Bell, Boyd & Lloyd, L.L.C. Vol#: 1
01E-0098 TNKase, Patent Extension Application No.5,385,732
N 1 Vol#: 1
01M-0439 PMA Deflux Injectable Gel, P000029
AAV 1 Q-Med AB Vol#: 1
01N-0398 Format and Content Requirements for OTC Drug Product Labelin
N 1 Vol#: 1
01N-0399 Rapid Response Surveys
N 1 Vol#: 1
01N-0400 Safety & Effectiveness of New Drug & Biological Products in
N 1 Vol#: 1
01P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
C 234 Mary Lou Jasken Vol#: 10
01P-0245 Determination that Disulfiram was withdrawn for reasons othe
N 1 Vol#: 1
01P-0396 Request that FDA ban the production and sale of all ephedra
EMC 1 Nik Willmore, PhD Vol#: 1
EMC 2 Denise Nance Vol#: 1
EMC 3 Ben Munguia Vol#: 1
01V-0448 Laser Light Show
ACK 1 HFA-305 Vol#: 1
VAR 1 Powerline Productions Vol#: 1